JVMTX
Price
$29.37
Change
+$0.26 (+0.89%)
Updated
Jun 2 closing price
Net Assets
22.49B
TASMX
Price
$30.75
Change
+$0.06 (+0.20%)
Updated
Jun 2 closing price
Net Assets
637.11M
Interact to see
Advertisement

JVMTX vs TASMX

Header iconJVMTX vs TASMX Comparison
Open Charts JVMTX vs TASMXBanner chart's image
JVMTX vs TASMX Comparison Chart in %
View a ticker or compare two or three
VS
JVMTX vs. TASMX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMTX is a Buy and TASMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMTX has more cash in the bank: 22.5B vs. TASMX (637M). TASMX pays higher dividends than JVMTX: TASMX (1.21) vs JVMTX (0.59). JVMTX was incepted earlier than TASMX: JVMTX (13 years) vs TASMX (11 years). JVMTX (1.10) is less costly to investors than TASMX (0.81). JVMTX (49.00) and TASMX (48.00) have comparable annual turnover. JVMTX (0) and TASMX (0) have matching initial minimum investment requirements. TASMX annual gain was more profitable for investors over the last year : 15.29 vs. JVMTX (6.89). JVMTX return over 5 years is better than : 4.06 vs. TASMX (-6.84).
JVMTXTASMXJVMTX / TASMX
Total Expense Ratio0.990.81122%
Annual Report Gross Expense Ratio1.100.81136%
Fund Existence13 years11 years-
Gain YTD6.12510.83457%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets22.5B637M3,532%
Annual Yield % from dividends0.591.2149%
Returns for 1 year6.8915.2945%
Returns for 3 years19.6318.36107%
Returns for 5 years4.06-6.84-59%
Returns for 10 years52.1327.89187%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VCRVX15.850.18
+1.15%
NYLI CBRE Global Infrastructure Inv Cl
RYRIX56.44N/A
N/A
Rydex Retailing Inv
IMOWX23.87N/A
N/A
Voya MidCap Opportunities W
STSNX41.10N/A
N/A
Sterling Capital SmCp Val A
SHSKX67.94N/A
N/A
BlackRock Health Sciences Opps K